Internship

Intern – Accounting Development Program

Posted on 11/26/2024

Bristol-Myers Squibb

Bristol-Myers Squibb

10,001+ employees

Develops and delivers biopharmaceutical medicines

Biotechnology
Healthcare

No H1B Sponsorship

Princeton, NJ, USA

All internships are based out of Central New Jersey.

Category
Cost Accounting
Financial Accounting
Financial Analysis
Management Accounting
Accounting
Required Skills
Data Analysis
Excel/Numbers/Sheets
Requirements
  • Currently enrolled student, on track to graduate by Spring 2026, seeking a Bachelor’s or Masters’ degree in accounting or finance from an accredited institution
  • Cumulative GPA of 3.0 or higher
  • Legal Authorization to work in the United States, without requiring sponsorship for employment visa status (e.g. H1-B status) now or in the future
  • Intermediate knowledge of Microsoft Excel
  • Proven capability to effectively communicate within work and/or academic environments, with the ability to adapt messages to suit various audiences
  • Ability and desire to sit for the Uniform CPA examination or CMA examination upon graduation
  • Interest in pursuing the full-time ADP program upon graduation
  • Demonstrated leadership experience within a school, extracurricular, and/or professional setting
  • Previous finance and/or accounting internship experience
  • Exposure or proficiency in manipulating large sets of data to perform robust analytics
  • Proven track record of working collaboratively in teams
  • Completion of accredited Excel or data visualization tool certificate program or course
  • Desire to work towards a leadership role in a large BioPharma company
  • Strong time management skills and the ability to work autonomously and within a team
Responsibilities
  • Specific responsibilities include controls testing, consolidation support, external reporting, analysis, and/or ad-hoc projects.

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and cardiovascular conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality and safety standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

Company Stage

IPO

Total Funding

$33.7B

Headquarters

New York City, New York

Founded

1887

Simplify Jobs

Simplify's Take

What believers are saying

  • BMS's partnership with Medidata enhances digital trial management and patient engagement.
  • The rise of personalized medicine allows BMS to develop targeted therapies for better outcomes.
  • BMS's commitment to ESG goals strengthens its brand reputation and stakeholder trust.

What critics are saying

  • Increased competition from companies like Light Horse Therapeutics may challenge BMS's market share.
  • BMS's lawsuit over the 340B Drug Pricing Program could lead to regulatory uncertainties.
  • Rapid AI adoption in trials may pose integration and data management challenges for BMS.

What makes Bristol-Myers Squibb unique

  • BMS focuses on oncology, immunology, and cardiovascular diseases for innovative treatments.
  • The company invests heavily in R&D to develop new drugs and therapies.
  • BMS offers both innovative and generic medicines, increasing healthcare accessibility.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

INACTIVE